PMID: 7538663May 1, 1995Paper

Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers

The Prostate
J VukanovicJ T Isaacs

Abstract

Linomide, a quinoline-3-carboxamide, has growth-inhibitory effects against a series of Dunning R-3327 rat prostatic cancers in vivo [Ichikawa et al.: Cancer Res 52:3022-3028, 1992]. In addition, we have demonstrated that daily linomide treatment can inhibit angiogenic responses in nontumor-bearing rats and reduce tumor blood flow in tumor-bearing rats [Vukanovic et al.: Cancer Res 53:1833, 1993]. In the present study we have demonstrated that the reduced tumor blood flow is due to linomide's ability to inhibit tumor angiogenesis, as documented by decreased number of blood vessels in prostatic carcinomas growing in rats treated daily with linomide. Due to linomide's ability to inhibit tumor angiogenesis, and since tumor angiogenesis is required not only for the growth of the primary cancer but also for its ability to metastasize, the effect of linomide on metastasis was directly tested using a quantitation metastasis assay. These in vivo experiments demonstrated that daily linomide treatment decreased by 3-fold the extent of dissemination of cancer cells to the lungs. To test if this antimetastatic response is due to direct effects of linomide on the metastatic cells themselves as well as an induced effect upon inhibition of tum...Continue Reading

References

Mar 1, 1992·Human Pathology·P T ScardinoM A Hudson
Jan 3, 1990·Journal of the National Cancer Institute·J Folkman
Dec 31, 1991·Biochemical and Biophysical Research Communications·T OikawaI Morita
Jan 2, 1991·Journal of the National Cancer Institute·R S Ungerleider, M A Friedman
May 1, 1990·Investigational New Drugs·E MissirlisM E Maragoudakis
Sep 1, 1987·Annals of Surgery·J Folkman, D E Ingber
Jan 1, 1987·International Journal of Immunopharmacology·E L LarssonT Stålhandske
Nov 1, 1988·Journal of Pharmaceutical Sciences·N LanderC C Gairola
Nov 1, 1986·Arthritis and Rheumatism·A TarkowskiT Stålhandske
Aug 1, 1972·The Journal of Experimental Medicine·M A GimbroneJ Folkman
Jan 1, 1984·British Journal of Cancer·A C Begg, K A Smith
Jul 15, 1983·Cancer·P N Brawn
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D M KarussisO Abramsky

❮ Previous
Next ❯

Citations

Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D RaghavanM Javle
Mar 20, 2003·Bioorganic & Medicinal Chemistry Letters·Jiandong ShiPui-Kai Li
Nov 12, 1998·Journal of the National Cancer Institute·I B Joseph, J T Isaacs
Feb 28, 2008·The Cancer Journal·Jeanny B Aragon-Ching, William L Dahut
May 11, 2013·Drug Design, Development and Therapy·Stuart Charles WilliamsonRakesh Heer
Jun 27, 1998·Connective Tissue Research·A NaglerS Shoshan
Apr 12, 2001·Cancer Investigation·M Choy, S Rafii
Oct 21, 2004·Cancer·David G BostwickBarry Timms
Oct 23, 1997·The Journal of Urology·S C Campbell
Aug 1, 1996·Lupus·G Zandman-GoddardY Shoenfeld
Mar 1, 1997·British Journal of Urology·S R Denmeade, J T Isaacs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.